within Pharmacolibrary.Drugs.ATC.J;

model J02AX07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.35,
    Cl             = 25 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,
    adminCount     = 1,
    Vd             = 0.6,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0014166666666666668,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Ibrexafungerp is a novel triterpenoid antifungal agent, approved for the treatment of vulvovaginal candidiasis (VVC) and is under investigation for other serious fungal infections. It has activity against a wide spectrum of Candida species, including strains resistant to azoles and echinocandins. Ibrexafungerp is orally administered and is the first-in-class oral glucan synthase inhibitor, representing a new option for antifungal therapy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult subjects following oral administration.</p><h4>References</h4><ol><li><p>McCarthy, MW (2022). Pharmacokinetics and Pharmacodynamics of Ibrexafungerp. <i>Drugs in R&amp;D</i> 22(1) 9–13. DOI:<a href=&quot;https://doi.org/10.1007/s40268-021-00376-x&quot;>10.1007/s40268-021-00376-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34961907/&quot;>https://pubmed.ncbi.nlm.nih.gov/34961907</a></p></li><li><p>Davis, MR, et al., &amp; Thompson, GR (2020). Ibrexafungerp: A novel oral glucan synthase inhibitor. <i>Medical mycology</i> 58(5) 579–592. DOI:<a href=&quot;https://doi.org/10.1093/mmy/myz083&quot;>10.1093/mmy/myz083</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31342066/&quot;>https://pubmed.ncbi.nlm.nih.gov/31342066</a></p></li><li><p>Sobel, JD (2022). Ibrexafungerp for the treatment of vulvovaginal candidiasis. <i>Drugs of today (Barcelona, Spain : 1998)</i> 58(4) 149–158. DOI:<a href=&quot;https://doi.org/10.1358/dot.2022.58.4.3381586&quot;>10.1358/dot.2022.58.4.3381586</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35412529/&quot;>https://pubmed.ncbi.nlm.nih.gov/35412529</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J02AX07;
